These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26608861)

  • 1. [IL-6 inhibitors prevent bone loss and cartilage degeneration in rheumatoid arthritis].
    Murakami M; Nishimoto N
    Clin Calcium; 2015 Dec; 25(12):1851-7. PubMed ID: 26608861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inflammatory cytokines in rheumatoid arthritis].
    Murakami M; Nishimoto N
    Clin Calcium; 2012 Nov; 22(11):1737-46. PubMed ID: 23103817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting interleukin-6 in rheumatoid arthritis.
    Choy E
    Curr Rheumatol Rep; 2008 Oct; 10(5):413-7. PubMed ID: 18817647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis.
    Azizi G; Jadidi-Niaragh F; Mirshafiey A
    Int J Rheum Dis; 2013 Jun; 16(3):243-53. PubMed ID: 23981743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6--a key mediator of systemic and local symptoms in rheumatoid arthritis.
    Cronstein BN
    Bull NYU Hosp Jt Dis; 2007; 65 Suppl 1():S11-5. PubMed ID: 17708739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting IL-6 for the treatment of rheumatoid arthritis: Phase II investigational drugs.
    Semerano L; Thiolat A; Minichiello E; Clavel G; Bessis N; Boissier MC
    Expert Opin Investig Drugs; 2014 Jul; 23(7):979-99. PubMed ID: 24766460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Anti-bone resorbing treatment for rheumatoid arthritis.].
    Tanaka Y
    Clin Calcium; 2018; 28(5):630-636. PubMed ID: 29731457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
    van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI
    Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What's the Difference?
    Avci AB; Feist E; Burmester GR
    BioDrugs; 2018 Dec; 32(6):531-546. PubMed ID: 30488231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined inhibition of tumor necrosis factor α and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibody.
    Fischer JA; Hueber AJ; Wilson S; Galm M; Baum W; Kitson C; Auer J; Lorenz SH; Moelleken J; Bader M; Tissot AC; Tan SL; Seeber S; Schett G
    Arthritis Rheumatol; 2015 Jan; 67(1):51-62. PubMed ID: 25303306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with inhibition of interleukin-6.
    Choy E
    Rheum Dis Clin North Am; 2004 May; 30(2):405-15, viii. PubMed ID: 15172049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Therapeutic intervention of rheumatoid arthritis bone loss].
    Ono K; Ohashi S; Tanaka S
    Clin Calcium; 2013 Sep; 23(9):1345-52. PubMed ID: 23999372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biochemical markers of bone turnover. New aspect. Therapy of rheumatoid arthritis for bone metabolic marker].
    Okada Y; Nawata M; Tanaka Y
    Clin Calcium; 2009 Aug; 19(8):1186-90. PubMed ID: 19638703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
    Nakahara H; Song J; Sugimoto M; Hagihara K; Kishimoto T; Yoshizaki K; Nishimoto N
    Arthritis Rheum; 2003 Jun; 48(6):1521-9. PubMed ID: 12794819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoids: novel therapies for arthritis?
    Dunn SL; Wilkinson JM; Crawford A; Le Maitre CL; Bunning RA
    Future Med Chem; 2012 Apr; 4(6):713-25. PubMed ID: 22530636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents.
    Lin HS; Hu CY; Chan HY; Liew YY; Huang HP; Lepescheux L; Bastianelli E; Baron R; Rawadi G; Clément-Lacroix P
    Br J Pharmacol; 2007 Apr; 150(7):862-72. PubMed ID: 17325656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
    Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T
    Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. META060 inhibits osteoclastogenesis and matrix metalloproteinases in vitro and reduces bone and cartilage degradation in a mouse model of rheumatoid arthritis.
    Konda VR; Desai A; Darland G; Bland JS; Tripp ML
    Arthritis Rheum; 2010 Jun; 62(6):1683-92. PubMed ID: 20201075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.